Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
33.71
+0.04 (0.12%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Supernus Pharmaceuticals Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for SUPN stock has a target of 36, which predicts an increase of 6.79% from the current stock price of 33.71.
Analyst Consensus: Hold
* Price targets were last updated on Sep 11, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for SUPN is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy → Hold Downgrades $41 → $36 | Buy → Hold | Downgrades | $41 → $36 | +6.79% | Sep 11, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $45 → $41 | Buy | Maintains | $45 → $41 | +21.63% | Feb 28, 2024 |
| Piper Sandler | Piper Sandler | Buy Maintains $42 → $43 | Buy | Maintains | $42 → $43 | +27.56% | Nov 9, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $43 → $42 | Buy | Maintains | $43 → $42 | +24.59% | Oct 25, 2023 |
| Piper Sandler | Piper Sandler | Buy Maintains $45 → $46 | Buy | Maintains | $45 → $46 | +36.46% | May 10, 2023 |
Financial Forecast
Revenue This Year
631.89M
from 607.52M
Increased by 4.01%
Revenue Next Year
632.51M
from 631.89M
Increased by 0.10%
EPS This Year
2.06
from 0.02
Increased by 10,202.00%
EPS Next Year
1.96
from 2.06
Decreased by -4.79%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 654.6M | 677.3M | 750.8M | ||
| Avg | 631.9M | 632.5M | 695.9M | ||
| Low | 602.8M | 583.9M | 613.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.7% | 7.2% | 18.7% | ||
| Avg | 4.0% | 0.1% | 10.0% | ||
| Low | -0.8% | -7.6% | -2.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 2.19 | 2.56 | 3.34 | ||
| Avg | 2.06 | 1.96 | 2.58 | ||
| Low | 1.91 | 1.16 | 1.47 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 10,872.5% | 24.3% | 70.2% | ||
| Avg | 10,202.0% | -4.8% | 31.4% | ||
| Low | 9,455.0% | -43.9% | -25.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.